Eli Lilly Net product revenue — Revenue increased by 12.1% to $18.30B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 52.2%, from $12.02B to $18.30B. Over 4 years (FY 2021 to FY 2025), Net product revenue — Revenue shows an upward trend with a 23.8% CAGR.
lly_segment_product_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.07B | $6.19B | $7.38B | $7.13B | $5.87B | $6.12B | $6.34B | $6.24B | $6.98B | $7.31B | $8.29B | $7.80B | $10.35B | $10.57B | $12.02B | $11.60B | $14.73B | $16.33B | $18.30B |
| QoQ Change | — | +2.0% | +19.2% | -3.3% | -17.7% | +4.2% | +3.6% | -1.6% | +11.9% | +4.7% | +13.5% | -5.9% | +32.8% | +2.1% | +13.7% | -3.5% | +26.9% | +10.9% | +12.1% |
| YoY Change | — | — | — | — | -3.3% | -1.1% | -14.1% | -12.5% | +18.9% | +19.4% | +30.8% | +25.0% | +48.4% | +44.7% | +45.1% | +48.8% | +42.2% | +54.5% | +52.2% |
We use cookies for analytics. See our Privacy and Cookie Policy.